Does Microneedling With Exosomes Really Work? What the Evidence Shows

Yes—but with an important qualification. Early human research suggests that combining microneedling with certain exosome or extracellular-vesicle preparations may improve skin texture, wrinkles, pigmentation, hydration and other measures of skin rejuvenation. However, the evidence is still developing: studies are generally small, use different products and protocols, and often have short follow-up. A 2026 systematic review concluded that the combination is promising but that larger, longer and better-controlled studies are still needed.

At Azani Medical Spa in Bethlehem, PA, we believe patients considering emerging aesthetic treatments deserve a straightforward answer—not hype.

So, does microneedling with exosomes really work?

The best answer based on the current evidence is: potentially yes, but it has not yet been proven to work consistently for every patient or every exosome product.

And there is another distinction that is extremely important:

Microneedling devices and exosome products have different FDA regulatory statuses.

Certain microneedling devices have been legally authorized by the FDA for specific aesthetic uses, including improvement in the appearance of facial acne scars and facial wrinkles in appropriate patients. However, the FDA states that there are currently no FDA-approved exosome products, and the FDA has not authorized microneedling devices to deliver cosmetics, drugs, biologics or other products into the skin.

At a Glance

What Is Microneedling With Exosomes?

Microneedling is a procedure that uses very small needles to create controlled micro-injuries in the skin.

The goal is to stimulate a wound-healing response and remodeling of the skin.

Exosomes are a subset of extracellular vesicles released by cells. They can carry biological signals, including proteins, lipids and nucleic-acid-related molecules, that participate in communication between cells.

When the two are combined, the proposed rationale is that microneedling creates a controlled skin-remodeling response while an exosome or extracellular-vesicle preparation may provide additional biological signaling.

That mechanism is biologically plausible.

But biological plausibility is not the same thing as clinical proof. That distinction is important throughout the exosome literature.

A 2026 review of facial aesthetics found substantial preclinical and clinical interest in exosomes, including research involving collagen, elastin, inflammation, oxidative stress and tissue remodeling, but emphasized that high-quality randomized controlled trials remain limited.

Does Microneedling Alone Really Work?

Yes—and this matters when evaluating exosomes. It would be misleading to attribute every improvement following an “exosome microneedling” treatment to the exosomes.

Microneedling itself has evidence behind it.

A 2025 systematic review evaluated 21 studies involving 723 patients undergoing microneedling for facial rejuvenation. Wrinkles were the most frequently evaluated endpoint, followed by skin texture, photoaging and skin laxity.

The FDA has also legally authorized certain microneedling devices for specific aesthetic indications, including improving the appearance of facial acne scars and facial wrinkles in patients aged 22 and older.

Therefore, when researchers ask whether adding exosomes makes microneedling better, the relevant comparison is not:

“Exosomes versus nothing.” It is: “Microneedling alone versus microneedling plus an exosome/extracellular-vesicle preparation.”

That is a much harder—and much more clinically meaningful—question.

The FDA has legally authorized certain microneedling devices for specific aesthetic uses, including improvement in the appearance of facial wrinkles and acne scars in appropriate patients. [FDA-authorized microneedling devices]

What Does the Research Say About Microneedling With Exosomes?

The newest systematic review is encouraging—but cautious. A 2026 systematic review specifically examined the use of microneedling combined with exosomes in dermatology. The authors concluded that the combination is promising but that larger studies and longer follow-up are needed. [2026 systematic review of microneedling combined with exosomes]

Researchers initially identified 256 unique references. After screening and quality appraisal, eight studies were included in the final narrative synthesis.

The studies involved sample sizes ranging from just 3 to 60 participants and examined conditions including:

• Skin aging
• Hyperpigmentation
• Scarring
• Enlarged pores
• Hair loss

The review concluded that microneedling and exosomes show promise, but emphasized that larger studies and longer follow-up are needed before the effectiveness and long-term safety of the combination can be established confidently.

This is one of the most important sources for answering the question posed by this article because it specifically evaluates the combination, rather than exosomes in general.

Is There Evidence That Exosomes Add Something to Microneedling?

Yes—there are signals that they may. But this is where the distinction between promising evidence and established evidence becomes important.

One prospective randomized split-face study evaluated 28 individuals with facial skin aging. Each participant received three treatment sessions. [View the randomized split-face study on PubMed]

One side of the face received microneedling combined with a human adipose tissue stem-cell-derived exosome-containing solution, while the other side received microneedling with saline as the control.

At final follow-up, the Global Aesthetic Improvement Scale score was significantly higher on the exosome-treated side. This type of split-face design is useful because each participant effectively serves as his or her own control.

However, the study was relatively small and follow-up was limited.

So it provides evidence of a possible incremental benefit, not definitive proof that exosomes always improve microneedling.

What Did a More Recent Microneedling Study Find?

A 2026 retrospective study evaluated 40 patients who received an exosome-containing skin booster together with microneedling.

Patients received four treatments at two-week intervals and were followed for eight weeks after the final treatment.

The investigators reported:

• 85% of patients scored “improved” or better on the Global Aesthetic Improvement Scale
• 87.5% overall satisfaction
• 82% intention to repeat treatment
• 85% willingness to recommend treatment

Reported adverse events were transient and mild, with no serious adverse reactions reported in that study.

Those results are encouraging. But there is an important limitation:

This was a retrospective study without a randomized control group.

Therefore, the study can tell us that patients appeared to improve following the treatment, but it cannot establish with the same confidence that the exosome component caused the improvement.

What About the Newest 2026 Randomized Study?

There is an especially interesting development because a randomized split-face study was published on August 24, 2026. The study evaluated 60 adults receiving radiofrequency microneedling. One side of the face received radiofrequency microneedling followed by a topical extracellular-vesicle preparation, while the opposite side received radiofrequency microneedling alone.

At 12 weeks, the EV-treated side showed greater improvement in wrinkle severity.

The investigators also reported numerical advantages for texture, pore visibility, erythema, pigmentation, hydration and Global Aesthetic Improvement Scale outcomes. Local reactions were transient and predominantly mild. This is important because it provides relatively recent controlled evidence that adding an extracellular-vesicle preparation may provide an incremental benefit over the procedure alone.

But even this study has limitations.

The investigators specifically noted:

• The study was unblinded
• Follow-up was only 12 weeks
• Histologic and molecular biomarkers were not included

Therefore, the results should be interpreted as a short-term efficacy signal, not proof of long-term regenerative effects. The study provides some of the most recent controlled human evidence evaluating extracellular-vesicle treatment alongside radiofrequency microneedling. [Read the August 2026 randomized study]

So, Does Microneedling With Exosomes Work Better Than Microneedling Alone?

The evidence suggests it might—but we cannot say that definitively yet. This is probably the single most important answer on this page. Some comparative human studies have found better outcomes when an exosome or extracellular-vesicle preparation is added to microneedling.

However:

• Studies are small
• Different products are used
• Different exosome sources are used
• Treatment protocols differ
• Follow-up periods differ
• Some studies are retrospective
• Some studies are unblinded
• Long-term data remain limited

The 2026 systematic review specifically examining microneedling plus exosomes concluded that more evidence is necessary before efficacy and safety can be established with confidence.

So the scientifically responsible answer is:

Microneedling with exosomes appears promising and may improve certain outcomes beyond microneedling alone, but the magnitude and consistency of that additional benefit have not yet been definitively established.

What Skin Problems Are Being Studied?

Research involving exosome-enhanced microneedling has explored several aesthetic concerns.

Fine lines and wrinkles

This is one of the most frequently studied outcomes.

Some studies report improvement in wrinkle appearance following combination treatment.

Skin texture

Studies have reported improvements in texture, including in comparative treatment designs.

Pigmentation

Hyperpigmentation and pigmentation-related measures have been evaluated in clinical research.

Some studies report improvement, but pigmentation is highly dependent on the underlying diagnosis and treatment protocol.

Skin hydration

Improved hydration has been reported in broader exosome-based skin-rejuvenation research and in recent comparative studies involving microneedling.

Elasticity

Elasticity is another commonly reported endpoint in exosome research. However, improvements in elasticity measured in a study do not necessarily translate into the same degree of visible improvement for every patient.

Acne scars

Both microneedling and exosome-based approaches have been studied in scar treatment. However, the evidence for the combination specifically remains limited. This is an important area where established microneedling evidence should not be confused with evidence for exosome augmentation.

Can Microneedling With Exosomes Stimulate Collagen?

There is a biological rationale and supportive early evidence. Microneedling itself initiates a wound-healing and remodeling response. Exosomes may influence signaling pathways involved in extracellular-matrix remodeling. Preclinical research has reported effects involving collagen, elastin and fibronectin, while clinical studies have reported improvements in skin elasticity and appearance.

But there is an important caveat.

Showing increased collagen-related activity in laboratory research does not prove that a cosmetic treatment will produce a clinically meaningful amount of new collagen in every patient.

The 2026 literature continues to call for better standardized human trials.

How Quickly Do You See Results?

Results are generally not expected to be instantaneous. Microneedling works partly through a biological remodeling process. The skin’s response develops over time rather than immediately after the procedure.

Published studies have used different follow-up periods, including several weeks and several months.

For example:

• One randomized split-face study followed patients for approximately 6 weeks after the final treatment.
• A 40-patient retrospective study followed patients for 8 weeks after the final treatment.
• The 2026 randomized radiofrequency microneedling study evaluated outcomes at 12 weeks.

This variation is another reason there is no scientifically established universal timeline such as “you will see results in exactly X days.”

How Many Treatments Are Usually Needed?

There is no universally established exosome-microneedling treatment schedule supported by high-quality evidence.

Clinical studies have used different protocols.

For example, the 40-patient retrospective study used four treatments at two-week intervals. The 2023 randomized split-face study used three treatment sessions separated by three weeks. That means treatment frequency should not simply be copied from one research study to every patient.

A physician-led treatment plan should consider:

• Skin condition
• Treatment depth
• Device
• Treatment area
• Product characteristics
• Skin response
• Desired outcome
• Recovery time

Does the Exosome Product Matter?

Absolutely.

One of the biggest problems in interpreting exosome research is that “exosome” is not a single standardized product.

Studies may use preparations derived from:

• Mesenchymal stromal/stem cells
• Adipose tissue
• Platelets
• Plants
• Other biological sources

The resulting products may differ in:

• Biological contents
• Purification
• Concentration
• Manufacturing
• Storage
• Stability
• Characterization

A 2026 scoping review of topical exosome products found substantial heterogeneity in commercially available products and limited information about isolation, processing and shelf life.

Therefore:

A study showing a benefit with one preparation does not prove that every product marketed as an “exosome” will produce the same result.

Does “Exosome” Automatically Mean the Product Is FDA Approved?

No. The FDA states that there are currently no FDA-approved exosome products. Patients can review the agency’s current information about [FDA-approved exosome products] and the regulatory status of regenerative medicine products.

The FDA also regulates exosome products and has warned about unapproved products marketed to patients.

Therefore, terms such as:

• “FDA registered”
• “FDA compliant”
• “FDA facility”
• “GMP manufactured”

should not be interpreted as meaning:

“This exosome product has been FDA approved for cosmetic skin rejuvenation.”

Those are different regulatory concepts.

Is Microneedling FDA Approved?

The terminology matters. The FDA does not simply “approve microneedling” as one universal treatment. The FDA has legally authorized specific microneedling medical devices for specific uses.

According to the FDA, authorized microneedling devices include indications involving improvement in the appearance of facial acne scars and facial wrinkles in appropriate patients. The FDA also notes that microneedling devices have not been cleared for delivery of cosmetics, topical medications, drugs or blood products into the skin.

That distinction is extremely important when discussing microneedling with exosomes.

Is Microneedling FDA Cleared to Deliver Exosomes Into the Skin?

No.

This is where many online explanations become misleading.

The fact that a particular microneedling device has FDA authorization for an aesthetic indication does not mean the FDA has approved the device as a delivery system for exosome products.

The FDA specifically states that microneedling devices have not been cleared for use with other products such as cosmetics, drugs or biologics to deliver those products into the skin.

Therefore, the combination should not be marketed as:

“FDA-approved exosome microneedling.”

That wording would be inaccurate.

What Does the Research Say About Safety?

Early studies generally report favorable short-term tolerability. Several clinical studies have reported mainly transient local reactions. For example, the 2026 retrospective study of 40 patients reported transient mild adverse events without serious adverse reactions during its follow-up period.

The August 2026 randomized split-face study similarly reported predominantly mild, transient local reactions. However, this should not be interpreted as proof of long-term safety.

A 2026 dermatology scoping review identified adverse events including granulomas, necrosis and allergic reactions in some exosome-related reports, particularly involving injection-based use.

The route of administration therefore matters. Topical application, microneedling-assisted application and injection are not interchangeable.

Why Is Product Quality Such an Important Issue?

Because the commercial exosome marketplace is highly heterogeneous.

A recent 2026 review examined commercially available topical exosome products and found major variation in:

• Claimed source
• Product composition
• Manufacturing information
• Processing information
• Shelf-life information

The authors concluded that greater standardization and stronger clinical evidence are needed.

This means that asking:”Do exosomes work?” is actually incomplete.

The more scientifically meaningful question is:“Does this specific preparation, delivered in this specific way, produce clinically meaningful benefits in humans?”

That is the question future research needs to answer more definitively.

Can You Tell From a Before-and-After Photo Whether Exosome Microneedling Works?

Not reliably. Before-and-after photographs can be useful for demonstrating a patient’s experience, but they cannot establish causation.

Appearance can change because of:

• Lighting
• Camera angle
• Makeup
• Hydration
• Skin care
• Natural healing
• Time
• Multiple treatments
• Image processing

Controlled studies are much more useful for determining whether a treatment actually caused an improvement. That is why randomized or split-face studies are particularly valuable.

Is Exosome Microneedling Better Than PRP?

There is currently not enough evidence to make a blanket statement that exosome microneedling is better than PRP. They are different biological approaches.

PRP uses components derived from the patient’s own blood.

Exosome products contain extracellular vesicles derived from a biological source that varies by product.

The evidence bases, preparation methods and regulatory considerations therefore differ.

Is Exosome Microneedling Better Than Microneedling Alone?

Possibly—but that is still the unanswered question.

The strongest evidence supporting the combination comes from comparative studies where one side or group received microneedling alone and the other received microneedling plus an extracellular-vesicle/exosome preparation.

Some of those studies show better outcomes with the combination.

But the evidence base is not yet large enough to determine:

• How large the benefit is
• Which patients benefit most
• Which product is optimal
• How many treatments are needed
• How long the benefit lasts
• Whether benefits persist for years

The April 2026 systematic review therefore concluded that more research is necessary.

What Is Known Versus What Is Still Unknown?

What Should You Ask Before Having Microneedling With Exosomes?

A well-informed patient should ask:

1. What exact product is being used?

“Exosomes” alone is not enough information.

2. What is the source of the extracellular vesicles?

Ask whether the source is human, plant-derived or another preparation.

3. What human studies have evaluated this exact product?

A study of another exosome preparation should not automatically be treated as evidence for the product being offered.

4. Is the product FDA approved?

As of the current FDA information, there are no FDA-approved exosome products.

5. What is the FDA status of the microneedling device?

Ask for the exact device rather than relying on a general statement that “microneedling is FDA approved.”

6. Is the microneedling device FDA-authorized for the intended use?

The FDA recommends checking the specific device’s authorization.

7. Is the combination itself FDA-cleared?

The FDA states that microneedling devices have not been cleared for delivery of cosmetics, drugs or biologics into the skin.

8. What results are realistic?

A responsible provider should discuss uncertainty as well as potential benefits.

Who May Be a Candidate?

Potential candidates may include adults interested in improving concerns such as:

• Fine lines
• Mild-to-moderate photoaging
• Uneven texture
• Certain pigmentation concerns
• Some types of acne scarring
• Overall skin quality

However, suitability depends on the individual.

The FDA notes that microneedling may not be appropriate for people with certain conditions or circumstances, including active skin infections, certain immune conditions, some bleeding disorders, uncontrolled diabetes, active rashes and other situations.

A medical consultation is therefore an important part of determining whether treatment is appropriate.

What Makes a Physician-Led Approach Different?

Emerging aesthetic treatments require more—not less—attention to patient selection.

At Azani Medical Spa in Bethlehem, PA, Dr. Monica Gavin, MD, approaches aesthetic treatments through individualized assessment rather than assuming that the newest technology is automatically the best option.

A consultation can consider:

• Your primary concern
• Skin type and condition
• Previous procedures
• Medical history
• Medications
• Pigmentation risk
• Scar history
• Desired outcome
• Recovery time
• The evidence supporting the proposed treatment

This is particularly important for exosome-based treatments because the scientific evidence is evolving and products are not standardized.

What Is the Bottom Line?

The evidence suggests that it can work—but “proven” would be too strong a word at this stage.

Microneedling itself has an established evidence base for several aesthetic indications.

Adding an exosome or extracellular-vesicle preparation has shown promising additional effects in several early human studies, including studies using randomized split-face designs. Recent 2026 research strengthens the case that there may be an incremental benefit.

But the overall evidence remains limited by:

• Small studies
• Different products
• Different treatment protocols
• Short follow-up
• Lack of blinding in some studies
• Limited high-quality randomized trials

The most accurate conclusion is therefore:

Microneedling with exosomes is a promising emerging aesthetic treatment, and early human studies suggest potential benefits beyond microneedling alone. However, the magnitude, consistency and long-term durability of that additional benefit remain uncertain.

And importantly:

There are currently no FDA-approved exosome products.

The FDA has authorized certain microneedling devices for specific uses, but that authorization should not be interpreted as FDA approval of exosome products or FDA clearance of microneedling as a delivery system for exosomes.

That is the evidence-based answer. 

Learn More About Microneedling With Exosomes

For the comprehensive overview of the treatment—including what exosomes are, potential benefits, safety considerations, FDA status and what to consider before treatment—read:

Microneedling With Exosomes: Benefits, Safety, Evidence & FDA Status

Schedule a Consultation

Considering microneedling with exosomes?

The right treatment depends on your skin, your goals and your medical history—not simply on whether a treatment is trending.

At Azani Medical Spa in Bethlehem, PA, Dr. Monica Gavin, MD, can evaluate your skin concerns and discuss whether microneedling, exosome-based approaches, or another evidence-supported treatment may be appropriate for you.

Meet Dr. Monica Gavin, MD

Dr. Monica Gavin, MD, is the physician associated with Azani Medical Spa in Bethlehem, Pennsylvania.

Azani Medical Spa takes a physician-led approach to aesthetic medicine, with an emphasis on individualized treatment planning, patient education, realistic expectations and informed decision-making.

For emerging technologies such as exosome-based treatments, this includes discussing both the potential benefits and the limitations of the current scientific evidence.

Medical Disclaimer

This article is intended for educational purposes only and is not a substitute for individualized medical advice, diagnosis or treatment. Exosome and extracellular-vesicle therapies are an evolving area of aesthetic medicine. Scientific evidence and regulatory status may change as additional research becomes available. Patients should discuss potential benefits, risks, alternatives and the regulatory status of any proposed treatment with a qualified healthcare professional.

Last reviewed: August 2026